Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Neumann

Showing results (411-420 of 1,206) with videos related to

Pageof 121
Sort By:
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|April 2, 2003
[Lymphomatoid papulosis type C or transition to CD30+-T-cell lymphoma? A difficult differential diagnosis]H Plettenberg, N J Neumann, T Ruzicka, et al.
International Journal of Technology Assessment in Health Care|September 28, 2004
Cross-national comparison of technology assessment processesAnna García-Altés, Silvia Ondategui-Parra, Peter J Neumann
Health Affairs (Project Hope)|June 5, 2013
Medicare covers the majority of FDA-approved devices and Part B drugs, but restrictions and discrepancies remainJames D Chambers, Katherine E May, Peter J Neumann
The New England Journal of Medicine|February 15, 2008
Does preventive care save money? Health economics and the presidential candidatesJoshua T Cohen, Peter J Neumann, Milton C Weinstein
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 13, 2022
The History and Future of the "ISPOR Value Flower": Addressing Limitations of Conventional Cost-Effectiveness AnalysisPeter J Neumann, Louis P Garrison, Richard J Willke
Mund-, Kiefer- Und Gesichtschirurgie : MKG|May 6, 1998
[Natural coral calcium carbonate as alternative substitute in bone defects of the skull]F Soost, B Reisshauer, A Herrmann, et al.
The New England Journal of Medicine|August 28, 2014
Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY thresholdPeter J Neumann, Joshua T Cohen, Milton C Weinstein
International Journal of Technology Assessment in Health Care|January 1, 1996
Potential savings from using information technology applications in health care in the United StatesP J Neumann, S T Parente, L C Paramore
Annual Review of Public Health|July 8, 2000
Preference-based measures in economic evaluation in health careP J Neumann, S J Goldie, M C Weinstein
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 26, 2018
A Health Economics Approach to US Value Assessment Frameworks-Introduction: An ISPOR Special Task Force Report [1]Peter J Neumann, Richard J Willke, Louis P Garrison
Pageof 121

Showing results (411-420 of 1,206) with videos related to

Sort By:
Pageof 121
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|April 2, 2003
[Lymphomatoid papulosis type C or transition to CD30+-T-cell lymphoma? A difficult differential diagnosis]H Plettenberg, N J Neumann, T Ruzicka, et al.
International Journal of Technology Assessment in Health Care|September 28, 2004
Cross-national comparison of technology assessment processesAnna García-Altés, Silvia Ondategui-Parra, Peter J Neumann
Health Affairs (Project Hope)|June 5, 2013
Medicare covers the majority of FDA-approved devices and Part B drugs, but restrictions and discrepancies remainJames D Chambers, Katherine E May, Peter J Neumann
The New England Journal of Medicine|February 15, 2008
Does preventive care save money? Health economics and the presidential candidatesJoshua T Cohen, Peter J Neumann, Milton C Weinstein
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 13, 2022
The History and Future of the "ISPOR Value Flower": Addressing Limitations of Conventional Cost-Effectiveness AnalysisPeter J Neumann, Louis P Garrison, Richard J Willke
Mund-, Kiefer- Und Gesichtschirurgie : MKG|May 6, 1998
[Natural coral calcium carbonate as alternative substitute in bone defects of the skull]F Soost, B Reisshauer, A Herrmann, et al.
The New England Journal of Medicine|August 28, 2014
Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY thresholdPeter J Neumann, Joshua T Cohen, Milton C Weinstein
International Journal of Technology Assessment in Health Care|January 1, 1996
Potential savings from using information technology applications in health care in the United StatesP J Neumann, S T Parente, L C Paramore
Annual Review of Public Health|July 8, 2000
Preference-based measures in economic evaluation in health careP J Neumann, S J Goldie, M C Weinstein
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 26, 2018
A Health Economics Approach to US Value Assessment Frameworks-Introduction: An ISPOR Special Task Force Report [1]Peter J Neumann, Richard J Willke, Louis P Garrison
Pageof 121